Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis

• Published in: International journal of epidemiology Vol. 42; no. 6; pp. 1754 - 1771
• Main Authors: DILLON, David G, GURDASANI, Deepti, RAMAIYA, Kaushik, NYAN, Ousman, ADEWOLE, Olanisun O, ANASTOS, Kathryn, AZZONI, Livio, BOOM, W. Henry, COMPOSTELLA, Caterina, DAVE, Joel A, DAWOOD, Halima, ERIKSTRUP, Christian, RIHA, Johanna, FOURIE, Carla M, FRIIS, Henrik, KRUGER, Annamarie, IDOKO, John A, LONGENECKER, Chris T, MBONDI, Suzanne, MUKAYA, Japheth E, MUTIMURA, Eugene, NDHLOVU, Chiratidzo E, PRAYGOD, George, EKORU, Kenneth, PEFURA YONE, Eric W, PUJADES-RODRIGUEZ, Mar, RANGE, Nyagosya, SANI, Mahmoud U, SCHUTTE, Aletta E, SLIWA, Karen, TIEN, Phyllis C, VORSTER, Este H, WALSH, Corinna, ZINYAMA, Rutendo, ASIKI, Gershim, MASHILI, Fredirick, SOBNGWI, Eugene, ADEBAMOWO, Clement, KAMALI, Anatoli, SEELEY, Janet, YOUNG, Elizabeth H, SMEETH, Liam, MOTALA, Ayesha A, KALEEBU, Pontiano, SANDHU, Manjinder S, MAYANJA, Billy N, LEVITT, Naomi S, CROWTHER, Nigel J, NYIRENDA, Moffat, NJELEKELA, Marina
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01.12.2013
• Subjects: Africa South of the Sahara - epidemiology; Anti-HIV Agents - therapeutic use; Antiretroviral Therapy, Highly Active - methods; Antiretroviral Therapy, Highly Active - statistics & numerical data; Biological and medical sciences; Body Mass Index; Diabetes Mellitus - epidemiology; Dyslipidemias - epidemiology; HIV Infections - drug therapy; HIV Infections - epidemiology; Human viral diseases; Humans; Hypertension - epidemiology; Infectious diseases; Medical sciences; Miscellaneous; Non-communicable Disease Risk Factors and Mortality; Public health. Hygiene; Public health. Hygiene-occupational medicine; Viral diseases; Viral diseases of the lymphoid tissue and the blood. Aids; Sub-Saharan Africa; Africa; Immunopathology; Art; Disease; Retroviridae; Systematic review; AIDS; Immune deficiency; Lentivirus; Metaanalysis; Infection; Virus; sub-Saharan Africa; Association; HIV; cardiometabolic disease; Viral disease; Human immunodeficiency virus; Public health; ART
• ISSN: 0300-5771; 1464-3685
• DOI: 10.1093/ije/dyt198

Sub-Saharan Africa (SSA) has the highest burden of HIV in the world and a rising prevalence of cardiometabolic disease; however, the interrelationship between HIV, antiretroviral therapy (ART) and cardiometabolic traits is not well described in SSA populations. We conducted a systematic review and meta-analysis through MEDLINE and EMBASE (up to January 2012), as well as direct author contact. Eligible studies provided summary or individual-level data on one or more of the following traits in HIV+ and HIV-, or ART+ and ART- subgroups in SSA: body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides (TGs) and fasting blood glucose (FBG) or glycated hemoglobin (HbA1c). Information was synthesized under a random-effects model and the primary outcomes were the standardized mean differences (SMD) of the specified traits between subgroups of participants. Data were obtained from 49 published and 3 unpublished studies which reported on 29 755 individuals. HIV infection was associated with higher TGs [SMD, 0.26; 95% confidence interval (CI), 0.08 to 0.44] and lower HDL (SMD, -0.59; 95% CI, -0.86 to -0.31), BMI (SMD, -0.32; 95% CI, -0.45 to -0.18), SBP (SMD, -0.40; 95% CI, -0.55 to -0.25) and DBP (SMD, -0.34; 95% CI, -0.51 to -0.17). Among HIV+ individuals, ART use was associated with higher LDL (SMD, 0.43; 95% CI, 0.14 to 0.72) and HDL (SMD, 0.39; 95% CI, 0.11 to 0.66), and lower HbA1c (SMD, -0.34; 95% CI, -0.62 to -0.06). Fully adjusted estimates from analyses of individual participant data were consistent with meta-analysis of summary estimates for most traits. Broadly consistent with results from populations of European descent, these results suggest differences in cardiometabolic traits between HIV-infected and uninfected individuals in SSA, which might be modified by ART use. In a region with the highest burden of HIV, it will be important to clarify these findings to reliably assess the need for monitoring and managing cardiometabolic risk in HIV-infected populations in SSA.